Hansen Medical(R) Announces First Shipment of a Magellan(TM) Robotic System to New York / New Jersey Metropolitan Area

MOUNTAIN VIEW, CA--(Marketwired - Oct 5, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the shipment of the Magellan Robotic System to Holy Name Medical Center in Teaneck, New Jersey, the first hospital in the New York / New Jersey metropolitan area to purchase a system. 

"We are excited for Holy Name Medical Center to be the first institution in the New York / New Jersey Metropolitan Area to offer robotic endovascular procedures with the Magellan Robotic System," said Dr. John Rundback, MD, Interventional Radiologist and Director of the Interventional Institute at Holy Name Medical Center. "The acquisition of a Magellan system by Holy Name reinforces our commitment to providing the most advanced, minimally invasive treatment options to patients in the region. We look forward to offering precise and predictable robotic procedures for the treatment of a wide variety of conditions, including peripheral vascular disease, uterine fibroids, cancer and enlarged prostates."

"Holy Name Medical Center is consistently at the leading edge of technology use," said Michael Maron, President and CEO of Holy Name. "We see it as the best way to ensure patient safety and better outcomes. The Magellan Robotic System is the next important step as Holy Name makes new advances in our region."

The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guide wires during minimally-invasive, endovascular procedures. Magellan is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy. Image-guided medical procedures using interventional fluoroscopy, while growing rapidly, are the leading source of occupational ionizing radiation exposure for medical personnel¹. Magellan's remote workstation allows physicians to control robotic catheters and guide wires while seated away from the radiation field, which has been shown to reduce radiation exposure for the physician by as much as 95% in complex endovascular procedures².

"Congratulations to Holy Name Medical Center on being the first hospital in its region to offer intravascular robotic procedures with Magellan," said Cary Vance, President and Chief Executive Officer of Hansen Medical. "We look forward to partnering with Holy Name and its Interventional Institute to bring advanced endovascular procedures to a large number of patients in the New York / New Jersey metropolitan area."